The Allstate Corporation

New York Stock Exchange
Bullish +65

Allstate (NYSE:ALL) Rating Increased to Buy at Wall Street Zen

πŸ“ˆ Wall Street Zen upgraded Allstate (NYSE:ALL) from 'hold' to 'buy' following strong quarterly performance.

πŸ’° The company reported Q1 earnings of $10.65 per share, significantly topping the $7.31 consensus estimate.

πŸ“Š Revenue reached $16.94 billion for the quarter, representing a 3.0% increase compared to the prior year.

πŸ“ˆ Net margin expanded to 17.81% with a return on equity of 42.66% during the reporting period.

🏦 Mitsubishi UFJ Asset Management increased its stake by 5.1% to own $112.5 million in shares.

πŸ“‰ COO Mario Rizzo sold 18,578 shares worth approximately $4.06 million in a May transaction.

🏒 Institutional ownership stands at 76.47% with several hedge funds raising positions in Q4.

🎯 Analyst consensus remains 'Moderate Buy' with an average price target of $254.80.

Bullish Signals
  • Allstate significantly beat earnings expectations, reporting $10.65 EPS against a consensus of $7.31.
  • Revenue grew 3.0% year-over-year to reach $16.94 billion, demonstrating solid top-line growth.
  • The company achieved a healthy net margin of 17.81% and a high return on equity of 42.66%.
  • Wall Street Zen upgraded the stock from 'hold' to 'buy', signaling improved analyst sentiment.
  • Mitsubishi UFJ Asset Management increased its stake by 5.1%, adding $26.6 million in new holdings.
  • Mezzasalma Advisors raised its position by 58.6% to acquire an additional $4.9 million in shares.
  • Morgan Stanley and Keefe, Bruyette & Woods both raised their price targets to $240 and $255 respectively.
Risk Factors
  • Director Andrea Redmond sold 2,225 shares worth $451,474.75 in a June transaction.
  • COO Mario Rizzo reduced his personal holdings by 18.43% by selling 18,578 shares in May.
  • Total insider sales reached 22,353 shares worth $4.85 million over the last 90 days.
Full Analysis
Wall Street Zen upgraded Allstate (NYSE:ALL) from a 'hold' to a 'buy' rating, citing strong recent performance. The upgrade joins a mixed analyst landscape where UBS maintained a buy but raised its price target to $261, while Keefe, Bruyette & Woods and Morgan Stanley also increased their targets to $255 and $240 respectively. Despite some neutral ratings from Atlantic Securities and Evercore, the consensus remains a 'Moderate Buy' with an average price target of $254.80. Allstate reported robust quarterly results on April 29th, significantly beating analyst expectations. The insurer posted earnings per share of $10.65 versus a consensus of $7.31 and revenue of $16.94 billion against an estimate of $15.24 billion. This performance drove a net margin of 17.81% and a return on equity of 42.66%, with revenue growing 3.0% year-over-year to reach $16.94 billion. Recent insider activity shows mixed signals, with Director Andrea Redmond selling 2,225 shares and COO Mario Rizzo reducing holdings by 18.43% in May and June. However, institutional investors have been net buyers, with Mitsubishi UFJ Asset Management increasing its stake by 5.1% to own over $112 million worth of stock, alongside significant position growth from Mezzasalma Advisors and Meyer Handelman Co.